Drug Trial Radar · NCT05327127
Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis
Last checked: Nov 19, 2026Latest source record: Jun 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
228
Actual
Start
Nov 14, 2022
Primary completion
May 20, 2026
Study completion Jun 3, 2026
Sponsor
- Lead sponsor
- Kowa Research Institute, Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 14, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A study to investigate the use of combination therapy with two investigational products for the treatment of adult patients with Nonalcoholic steatohepatitis (NASH).
Conditions
- NASH
Interventions
K-877-ERDrug
K-877-ER tablet
CSG452Drug
CSG452 tablet
PlaceboDrug
Placebo tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Improvement in disease activity and no worsening of liver fibrosis (Yes/No)Time frame: Baseline to Week 48
Locations
77 sites in 6 countries. Site status is shown where the registry gives one.
Adobe Clinical Research, LLC
Tucson, Arizona
Arizona Liver Health
Tucson, Arizona
Arcare Center for Clinical Research
Little Rock, Arkansas
Clinical Trials Research
Lincoln, California
United Clinical Research Institute
Los Alamitos, California
Velocity Clinical Research
Los Angeles, California
Alliance Clinical Research
Poway, California
Nature Coast Clinical Research, LLC
Inverness, Florida
ENCORE Borland Groover Clinical Research
Jacksonville, Florida
Miami Clinical Research
Miami, Florida
Ocala GI Research
Ocala, Florida
Sensible Healthcare Clinical Research, LLC
Ocoee, Florida
Centricity Research
Columbus, Georgia
Gastrointestinal Specialists of Georgia, PC
Marietta, Georgia
Iowa Digestive Disease Center
Clive, Iowa
Tandem Clinical Research, LLC
Marrero, Louisiana
Mid-Atlantic GI Research, LLC
Greenbelt, Maryland
Boston Medical Center Boston University Chobanian & Avedisian School of Medicine
Boston, Massachusetts
University of Michigan
Ann Arbor, Michigan
GI Alliance Research
Flowood, Mississippi
GI Associates Research, LLC
Columbia, Missouri
Jefferson City Medical Group
Jefferson City, Missouri
Lucas Research, Inc.
Morehead City, North Carolina
DSI Research Northridge, LLC
Dayton, Ohio
Penn State Health/Penn State College of Medicine
Hershey, Pennsylvania
GI Alliance Research
Cedar Park, Texas
GI Alliance Research
Dallas, Texas
GI Alliance Research
Garland, Texas
GLRI McAllen Research
Pharr, Texas
Northeast Clinical Rsearch of San Antonio
San Antonio, Texas
Endeavor Clinical Trials
San Antonio, Texas
Impact Research Institute
Waco, Texas
Digestive Health Research of Central Texas, LLC
Waco, Texas
North Richmond Health Research
Richmond, Virginia
GI Select Health Research
Richmond, Virginia
Centricity
Suffolk, Virginia
Liver Institute Northwest
Seattle, Washington
Hospital Italiano de Buenos Aires
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
CINME - Centro De Investigaciones Metabolicas
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Hospital Italiano de La Plata
La Plata, Buenos Aires, Argentina
Showing 40 of 77 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.